Picture of Sanofi SA logo

SAN — Sanofi SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Sanofi: Subcutaneous Sarclisa Escena Approved In US

BRIEF-Sanofi: Subcutaneous Sarclisa Escena Approved In US

- Sanofi SA SASY.PA:

  • SANOFI'S SUBCUTANEOUS SARCLISA ESCENA APPROVED IN US AS FIRST ANTICANCER TREATMENT ADMINISTERED VIA ON-BODY INJECTOR

  • FDA APPROVES SUBCUTANEOUS SARCLISA ESCENA FOR MULTIPLE MYELOMA

Source text: ID:nGNE53glWs

Further company coverage: SASY.PA


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Sanofi SA

See all news